Cerity Partners’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,853
| Closed | -$249K | – | 2788 |
|
|
2025
Q1 | $249K | Sell |
13,853
-357
| -3% | -$6.35K | ﹤0.01% | 2114 |
|
|
2024
Q4 | $244K | Buy |
14,210
+276
| +2% | +$3.73K | ﹤0.01% | 2136 |
|
|
2024
Q3 | $160K | Sell |
13,934
-383
| -3% | -$4.39K | ﹤0.01% | 2366 |
|
|
2024
Q2 | $162K | Sell |
14,317
-1,566
| -10% | -$20.8K | ﹤0.01% | 2059 |
|
|
2024
Q1 | $227K | Buy |
15,883
+2,883
| +22% | +$40.9K | ﹤0.01% | 2039 |
|
|
2023
Q4 | $178K | Buy |
+13,000
| New | +$137K | ﹤0.01% | 1740 |
|
|
2023
Q3 | – | Sell |
-13,000
| Closed | -$98.4K | – | 1746 |
|
|
2023
Q2 | $98.4K | Hold |
13,000
| – | – | ﹤0.01% | 1549 |
|
|
2023
Q1 | $104K | Buy |
13,000
+3,000
| +30% | +$30.9K | ﹤0.01% | 1770 |
|
|
2022
Q4 | $114K | Hold |
10,000
| – | – | ﹤0.01% | 1401 |
|
|
2022
Q3 | $87K | Hold |
10,000
| – | – | ﹤0.01% | 1122 |
|
|
2022
Q2 | $100K | Hold |
10,000
| – | – | ﹤0.01% | 1125 |
|
|
2022
Q1 | $101K | Hold |
10,000
| – | – | ﹤0.01% | 895 |
|
|
2021
Q4 | $127K | Hold |
10,000
| – | – | ﹤0.01% | 965 |
|
|
2021
Q3 | $125K | Hold |
10,000
| – | – | ﹤0.01% | 665 |
|
|
2021
Q2 | $151K | Hold |
10,000
| – | – | ﹤0.01% | 687 |
|
|
2021
Q1 | $137K | Hold |
10,000
| – | – | ﹤0.01% | 675 |
|
|
2020
Q4 | $181K | Hold |
10,000
| – | – | 0.01% | 611 |
|
|
2020
Q3 | $127K | Buy |
+10,000
| New | +$125K | 0.01% | 482 |
|
Cerity Partners's PTVE Position: Q2 2025 in Review
Cerity Partners sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 13,853 shares — an estimated $249K sold.
Cerity Partners first reported a position in PTVE in Q3 2020 and held it in 18 quarters. The position peaked at $249K in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.
- Cerity Partners reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
- Cerity Partners sold 13,853 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $249K.
- Cerity Partners first reported a position in Pactiv Evergreen Inc. Common stock in Q3 2020 and held it in 18 quarters.
- Cerity Partners's Pactiv Evergreen Inc. Common stock position peaked at $249K in Q1 2025.
- 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.
Based on Cerity Partners's 13F filing for Q2 2025, filed 13 Aug 2025.